NCT02420873
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, Hematologic Diseases, +21 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Myeloproliferative Disorders
Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.
1,108 public trials
143 recruiting studies
Myeloproliferative Disorders trial results
Completed
AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT01253447
- Conditions
- Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +27 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00295841
- Conditions
- Bone Marrow Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
- Locations
-
- Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States
NCT00795002
- Conditions
- Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +29 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01535391
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
- Locations
-
- Azienda Ospedaliera Nuovo Ospedale "Torrette" Ancona, Italy
- S.G. Moscati Hospital Avellino, Italy
- Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi Bologna, Italy
- USD Trapianti di midollo per adulti - Cattedra di Ematologia - Università degli Studi di Brescia Brescia, Italy
Completed
Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
NCT00809211
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
- Locations
-
- University of Texas Health Science Center at San Antonio San Antonio, Texas, United States
- Universitätsklinikum Charité Berlin Berlin, Germany
- Belfast City Hospital Belfast, Ireland
- St. James's Hospital Dublin, Ireland
NCT01484015
- Conditions
- Adnexal Diseases, Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, +121 more
- Locations
-
- Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
NCT00467961
- Conditions
- AML (Acute Myelogenous Leukemia), Acute Lymphocytic Leukemia, Anemia, +28 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT02226861
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +24 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT01517035
- Conditions
- Acute Lymphoblastic Leukemia, Bone Marrow Diseases, CLL (Chronic Lymphocytic Leukemia), +23 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States